5-Bromo-2-methoxyphenylboronic Acid (contains varying amounts of Anhydride)>98.0%(HPLC)5g

4-(4-Hydroxyphenyl)-4-oxobutanoic acid, 97%, 250mg

2,6-Difluoro-3-iodoanisole, 98%, 25g

Lithium 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoate, 95%, 250mg

Ethyl 4,6-dichloropyrimidine-5-carboxylate, 95.0%, 100mg

4-Chloro-6-hydrazinyl-2-MethylpyriMidine, 95%, 100mg

4'-(Trifluoromethoxy)acetophenone>98.0%(GC)5g

cis-4-(Aminomethyl)cyclohexanol hydrochloride, 98+%, 250mg

3-(2-Chloro-4-fluorophenyl)propionic acid, 95.0%, 10g

Colonne capillaire GC ROTI®Cap-1, 60 m, 0,25 mm, 0,50 µm, 1 pièce(s)

4,4,4-Trifluoro-1-(pyridine-4-yl)-1,3-butanedione, 95.0%, 1g

4-Ethyl-4-methylmorpholin-4-ium bromide, 95.0%, 5g

6-Amino-2-chloropurine, 97.0%, 5g